viking therapeutics dark horse glp-1 Viking Therapeutics Enters the GLP-1 Market and VKTX is Soaring Overview - Viking Therapeutics
Description
A Trimi survey of 1,065 U.S
Youve likely heard about the incredible results of GLP-1 (glucagon-like peptide-1) medications, such as semaglutide, liraglutide, and tirzepatide, for
#AutoimmuneHealth #GLP1 #BiologicTherapy #RheumatoidArthritis #PsoriaticArthritis #InflammationCare
May 27, 2026
Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.1 billion takeover of Carmot Therapeutics
